secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIFECORE BIOMEDICAL, INC. DE (LFCR)
CIK:        0001005286
Form:       8-K
Filed at:   2024-05-16T23:59:59+00:00
Accession:  0001005286-24-000067
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lifecore adds ~$8M non-dilutive liquidity via lender amendments; assigns Curation Foods assets
--------------------------------------------------------------------------------

- $5.5M prepayment from term lender as advance on future purchases; lender can apply to invoices in 2026.
- FILO amendment adds ~$2.5M incremental revolver capacity under ABL; margin SOFR+4.25%, annual interest +~$44k.
- Assignment for benefit of creditors of wholly owned subsidiary Curation Foods to SG Service Co. for liquidation.
- Pro forma cash post-initiatives would be $11.0M (up from $3.0M); total debt $178.9M.
- 2024 Annual Incentive Plan amended: CEO & CFO cash incentives to be paid in unrestricted common stock.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1005286/000100528624000067/0001005286-24-000067-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1005286/000100528624000067/lndc-20240516.htm
  HTML page:      https://secwatch.observer/filing/0001005286-24-000067

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer